HomeCompareMYRX vs DIVO

MYRX vs DIVO: Dividend Comparison 2026

MYRX yields 333333.33% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MYRX wins by $8.099219044190773e+31M in total portfolio value
10 years
MYRX
MYRX
● Live price
333333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.099219044190773e+31M
Annual income
$80,944,421,463,343,720,000,000,000,000,000,000,000.00
Full MYRX calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — MYRX vs DIVO

📍 MYRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMYRXDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MYRX + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MYRX pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MYRX
Annual income on $10K today (after 15% tax)
$28,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$68,802,758,243,842,160,000,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, MYRX beats the other by $68,802,758,243,842,160,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MYRX + DIVO for your $10,000?

MYRX: 50%DIVO: 50%
100% DIVO50/50100% MYRX
Portfolio after 10yr
$4.0496095220953863e+31M
Annual income
$40,472,210,731,671,860,000,000,000,000,000,000,000.00/yr
Blended yield
99.94%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MYRX buys
0
DIVO buys
0
No recent congressional trades found for MYRX or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMYRXDIVO
Forward yield333333.33%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.099219044190773e+31M$30.7K
Annual income after 10y$80,944,421,463,343,720,000,000,000,000,000,000,000.00$981.68
Total dividends collected$8.098906375781879e+31M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MYRX vs DIVO ($10,000, DRIP)

YearMYRX PortfolioMYRX Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$33,344,033$33,333,333.33$11,349$649.42+$33.33MMYRX
2$103,911,171,366$103,875,493,250.26$12,833$688.83+$103911.16MMYRX
3$302,644,656,190,810$302,533,471,237,448.00$14,459$727.90+$302644656.18MMYRX
4$823,817,797,451,856,400$823,493,967,669,732,100.00$16,238$766.49+$823817797451.84MMYRX
5$2,095,836,995,961,804,000,000$2,094,955,510,918,530,000,000.00$18,179$804.47+$2095836995961804.00MMYRX
6$4,983,251,920,823,462,000,000,000$4,981,009,375,237,783,000,000,000.00$20,293$841.71+$4983251920823461888.00MMYRX
7$11,073,835,968,753,321,000,000,000,000$11,068,503,889,198,040,000,000,000,000.00$22,591$878.14+$1.1073835968753322e+22MMYRX
8$22,999,277,308,531,336,000,000,000,000,000$22,987,428,304,044,770,000,000,000,000,000.00$25,087$913.65+$2.2999277308531335e+25MMYRX
9$44,643,905,199,991,210,000,000,000,000,000,000$44,619,295,973,271,085,000,000,000,000,000,000.00$27,791$948.18+$4.464390519999121e+28MMYRX
10$80,992,190,441,907,720,000,000,000,000,000,000,000$80,944,421,463,343,720,000,000,000,000,000,000,000.00$30,718$981.68+$8.099219044190773e+31MMYRX

MYRX vs DIVO: Complete Analysis 2026

MYRXStock

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

Full MYRX Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this MYRX vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MYRX vs SCHDMYRX vs JEPIMYRX vs OMYRX vs KOMYRX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.